Cargando…
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments
The pharmacological treatment of cognitive impairments associated with schizophrenia is still a major unmet clinical need. Indeed, treatments with available antipsychotics generate highly variable cognitive responses among patients with schizophrenia. This has led to the general assumption that anti...
Autores principales: | Torrisi, Sebastiano Alfio, Laudani, Samuele, Contarini, Gabriella, De Luca, Angelina, Geraci, Federica, Managò, Francesca, Papaleo, Francesco, Salomone, Salvatore, Drago, Filippo, Leggio, Gian Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694365/ https://www.ncbi.nlm.nih.gov/pubmed/33167370 http://dx.doi.org/10.3390/ph13110365 |
Ejemplares similares
-
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017) -
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates
por: Bellotti, Elena, et al.
Publicado: (2022) -
Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta
por: Zingales, Veronica, et al.
Publicado: (2021) -
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2019) -
Acute stress alters recognition memory and AMPA/NMDA receptor subunits in a sex-dependent manner
por: Torrisi, Sebastiano A., et al.
Publicado: (2023)